Stratasys Releases First Quarter 2025 Financial Results
-
Revenue of
$136.0 million , compared to$144.1 million in the prior year period -
GAAP net loss of
$13.1 million , or$0.18 per diluted share, and non-GAAP net income of$2.9 million , or$0.04 per diluted share -
Adjusted EBITDA of
$8.2 million , compared to$4.1 million in the prior year period -
$150.1 million cash, equivalents and short-term deposits and no debt atMarch 31, 2025 -
Adds
$120 million in cash from investment byFortissimo Capital subsequent to quarter end - Raises 2025 Outlook
Dr.
Summary - First Quarter 2025 Financial Results Compared to First Quarter 2024:
-
Revenue of
$136.0 million compared to$144.1 million . - GAAP gross margin of 44.3%, compared to 44.4%.
- Non-GAAP gross margin of 48.3%, compared to 48.6%.
-
GAAP operating loss of
$12.4 million , compared to an operating loss of$24.5 million . -
Non-GAAP operating income of
$3.0 million , compared to an operating loss of$1.2 million . -
GAAP net loss of
$13.1 million , or$0.18 per diluted share, compared to a net loss of$26.0 million , or$0.37 per diluted share. -
Non-GAAP net income of
$2.9 million , or$0.04 per diluted share, compared to a net loss of$1.7 million , or$0.02 per diluted share. -
Adjusted EBITDA of
$8.2 million , compared to$4.1 million . -
Cash provided by operating activities of
$4.5 million , compared to$7.3 million .
Financial Outlook:
Based on current market conditions and assuming that the impacts of tariff policy, global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is reiterating the following outlook for 2025:
-
Full year revenue of
$570 million to$585 million , improving sequentially over the course of the year. - Based on current logistics and materials costs, full-year non-GAAP gross margins of 48.8%-49.2%, improving sequentially over the course of the year.
-
Full year operating expenses in a range of
$254 million to$257 million . - Full year non-GAAP operating margins in a range of 4.0% to 5.0%.
-
Adjusted EBITDA of
$44 million to$50 million , or 7.8% to 8.5% of revenue. -
Capital expenditures of
$25 million to$30 million . - Expects to generate improved operating and free cashflow, at higher levels than in 2024.
As a result of the Fortissimo investment, the Company’s share count as of
-
GAAP net loss of
$64 million to$49 million , up from$68 million to$53 million previously, and GAAP EPS of ($0.80 ) to ($0.61 ), an improvement as compared to ($0.93 ) to ($0.72 ) previously. -
Non-GAAP net income of
$24 million to$30 million , up from$20 million to$26 million previously, and Non-GAAP EPS of$0.30 to$0.37 , up from$0.28 to$0.35 previously.
Appropriate reconciliations between our historical GAAP and non-GAAP financial measures, as well as between the GAAP and non-GAAP financial measures included in our updated financial outlook for 2025, are provided in the tables at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures. We have not included, however, a reconciliation of our guidance for non-GAAP gross margins to the most directly comparable GAAP financial measure, as we are unable to do so without unreasonable effort or with reasonable certainty from a quantitative perspective.
The Company plans to webcast its conference call to discuss its first quarter 2025 financial results on
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=pGlPRdRX
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions, (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in the tables below.
|
||||||||||
Consolidated Balance Sheets | ||||||||||
( |
||||||||||
(Unaudited) | ||||||||||
|
|
|||||||||
ASSETS | ||||||||||
Current assets | ||||||||||
Cash and cash equivalents |
$ |
70,061 |
|
$ |
70,200 |
|
||||
Short-term bank deposits |
|
80,000 |
|
|
80,500 |
|
||||
Accounts receivable, net of allowance for credit losses of |
|
156,150 |
|
|
152,979 |
|
||||
Inventories |
|
169,881 |
|
|
179,809 |
|
||||
Prepaid expenses |
|
10,616 |
|
|
7,630 |
|
||||
Other current assets |
|
20,923 |
|
|
21,843 |
|
||||
Total current assets |
|
507,631 |
|
|
512,961 |
|
||||
Non-current assets | ||||||||||
Property, plant and equipment, net |
|
186,866 |
|
|
184,379 |
|
||||
|
|
99,463 |
|
|
99,082 |
|
||||
Other intangible assets, net |
|
101,619 |
|
|
106,253 |
|
||||
Operating lease right-of-use assets |
|
31,097 |
|
|
32,169 |
|
||||
Long-term investments |
|
81,518 |
|
|
80,205 |
|
||||
Other non-current assets |
|
14,950 |
|
|
14,697 |
|
||||
Total non-current assets |
|
515,513 |
|
|
516,785 |
|
||||
Total assets |
$ |
1,023,144 |
|
$ |
1,029,746 |
|
||||
LIABILITIES AND EQUITY | ||||||||||
Current liabilities | ||||||||||
Accounts payable |
$ |
38,032 |
|
$ |
44,977 |
|
||||
Accrued expenses and other current liabilities |
|
36,310 |
|
|
39,749 |
|
||||
Accrued compensation and related benefits |
|
34,905 |
|
|
29,206 |
|
||||
Deferred revenues - short-term |
|
51,897 |
|
|
46,347 |
|
||||
Operating lease liabilities - short-term |
|
6,921 |
|
|
6,935 |
|
||||
Total current liabilities |
|
168,065 |
|
|
167,214 |
|
||||
Non-current liabilities | ||||||||||
Deferred revenues - long-term |
|
20,138 |
|
|
19,057 |
|
||||
Deferred income taxes |
|
459 |
|
|
507 |
|
||||
Operating lease liabilities - long-term |
|
24,363 |
|
|
25,155 |
|
||||
Contingent consideration - long-term |
|
5,089 |
|
|
4,933 |
|
||||
Other non-current liabilities |
|
20,189 |
|
|
19,889 |
|
||||
Total non-current liabilities |
|
70,238 |
|
|
69,541 |
|
||||
Total liabilities |
$ |
238,303 |
|
$ |
236,755 |
|
||||
Contingencies (see note 12) | ||||||||||
Equity | ||||||||||
Ordinary shares, |
$ |
203 |
|
$ |
202 |
|
||||
|
|
(1,995 |
) |
|
(1,995 |
) |
||||
Additional paid-in capital |
|
3,129,236 |
|
|
3,123,024 |
|
||||
Accumulated other comprehensive loss |
|
(9,340 |
) |
|
(8,031 |
) |
||||
Accumulated deficit |
|
(2,333,263 |
) |
|
(2,320,209 |
) |
||||
Total equity |
|
784,841 |
|
|
792,991 |
|
||||
Total liabilities and equity |
$ |
1,023,144 |
|
$ |
1,029,746 |
|
|
|||||||||
Consolidated Statements of Operations | |||||||||
( |
Three Months Ended |
||||||||
(Unaudited) |
2025 |
2024 |
|||||||
Revenues | |||||||||
Products |
$ |
93,795 |
|
$ |
99,196 |
|
|||
Services |
|
42,251 |
|
|
44,854 |
|
|||
|
136,046 |
|
|
144,050 |
|
||||
Cost of revenues | |||||||||
Products |
|
47,268 |
|
|
49,757 |
|
|||
Services |
|
28,539 |
|
|
30,396 |
|
|||
|
75,807 |
|
|
80,153 |
|
||||
Gross profit |
|
60,239 |
|
|
63,897 |
|
|||
Operating expenses | |||||||||
Research and development, net |
|
18,792 |
|
|
23,977 |
|
|||
Selling, general and administrative |
|
53,851 |
|
|
64,373 |
|
|||
|
72,643 |
|
|
88,350 |
|
||||
Operating loss |
|
(12,404 |
) |
|
(24,453 |
) |
|||
Financial income, net |
|
1,473 |
|
|
1,217 |
|
|||
Loss before income taxes |
|
(10,931 |
) |
|
(23,236 |
) |
|||
Income tax expense |
|
455 |
|
|
716 |
|
|||
Share in losses of associated companies |
|
1,668 |
|
|
2,031 |
|
|||
Net loss |
$ |
(13,054 |
) |
$ |
(25,983 |
) |
|||
Net loss per ordinary share- basic and diluted |
$ |
(0.18 |
) |
$ |
(0.37 |
) |
|||
Weighted average ordinary shares outstanding- basic and diluted |
|
71,967 |
|
|
69,993 |
|
|||
|
||||||||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Results of Operations | ||||||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||||||
2025 |
Non-GAAP |
2025 |
2024 |
Non-GAAP |
2024 |
|||||||||||||||||||
GAAP |
Adjustments |
Non-GAAP |
GAAP |
Adjustments |
Non-GAAP |
|||||||||||||||||||
|
||||||||||||||||||||||||
Gross profit (1) |
$ |
60,239 |
|
$ |
5,410 |
|
$ |
65,649 |
$ |
63,897 |
|
$ |
6,139 |
|
$ |
70,036 |
|
|||||||
Operating income (loss) (1,2) |
|
(12,404 |
) |
|
15,450 |
|
|
3,046 |
|
(24,453 |
) |
|
23,254 |
|
|
(1,199 |
) |
|||||||
Net income (loss) (1,2,3) |
|
(13,054 |
) |
|
15,932 |
|
|
2,878 |
|
(25,983 |
) |
|
24,299 |
|
|
(1,684 |
) |
|||||||
Net income (loss) per diluted share (4) |
$ |
(0.18 |
) |
$ |
0.22 |
|
$ |
0.04 |
$ |
(0.37 |
) |
$ |
0.35 |
|
$ |
(0.02 |
) |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
4,488 |
|
|
5,084 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
708 |
|
|
952 |
|
||||||||||||||||||
Restructuring and other related costs |
|
214 |
|
|
103 |
|
||||||||||||||||||
|
5,410 |
|
|
6,139 |
|
|||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
940 |
|
|
2,459 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
5,505 |
|
|
7,697 |
|
||||||||||||||||||
Restructuring and other related costs |
|
1,132 |
|
|
920 |
|
||||||||||||||||||
Revaluation of investment |
|
- |
|
|
1,900 |
|
||||||||||||||||||
Contingent consideration |
|
645 |
|
|
511 |
|
||||||||||||||||||
Legal and other expenses |
|
1,818 |
|
|
3,628 |
|
||||||||||||||||||
|
10,040 |
|
|
17,115 |
|
|||||||||||||||||||
|
15,450 |
|
|
23,254 |
|
|||||||||||||||||||
(3) |
Corresponding tax effect |
|
84 |
|
|
234 |
|
|||||||||||||||||
Equity method related expenses |
|
841 |
|
|
964 |
|
||||||||||||||||||
Finance income |
|
(443 |
) |
|
(153 |
) |
||||||||||||||||||
$ |
15,932 |
|
$ |
24,299 |
|
|||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
71,967 |
|
|
72,625 |
|
69,993 |
|
|
69,993 |
|
|
|||||||
Reconciliation of GAAP net loss to Adjusted EBITDA | |||||||
Three months ended |
|||||||
2025 |
2024 |
||||||
( |
|||||||
Net loss |
$ |
(13,054 |
) |
$ |
(25,983 |
) |
|
Financial income, net |
|
(1,473 |
) |
|
(1,217 |
) |
|
Income tax expenses |
|
455 |
|
|
716 |
|
|
Share in losses of associated companies |
|
1,668 |
|
|
2,031 |
|
|
Depreciation expenses |
|
5,124 |
|
|
5,305 |
|
|
Amortization expenses |
|
5,428 |
|
|
7,543 |
|
|
Non-cash stock-based compensation expense |
|
6,213 |
|
|
8,649 |
|
|
Revaluation of investment |
|
- |
|
|
1,900 |
|
|
Contingent consideration |
|
645 |
|
|
511 |
|
|
Legal and other expenses |
|
1,818 |
|
|
3,628 |
|
|
Restructuring and other related costs |
|
1,346 |
|
|
1,023 |
|
|
Adjusted EBITDA |
$ |
8,170 |
|
$ |
4,106 |
|
|
|
Reconciliation of GAAP Net Loss to Non-GAAP Net Income Forward Looking Guidance: | |
Fiscal Year 2025 | |
( |
|
GAAP net loss |
|
Adjustments | |
Stock-based compensation expense |
|
Intangible assets amortization expense |
|
Reorganization and other |
|
Tax expense related to Non-GAAP adjustments |
|
Non-GAAP net income |
|
GAAP loss per share |
|
Non-GAAP diluted earnings per share |
|
Reconciliation of GAAP Net Loss to Adjusted EBITDA Forward Looking Guidance: | |
Fiscal Year 2025 | |
( |
|
GAAP net loss |
|
Adjustments | |
Stock-based compensation expense |
|
Intangible assets amortization expense |
|
Reorganization and other |
|
Tax expense related to Non-GAAP adjustments |
|
Other non-operating expense | $- to $- |
Depreciation |
|
Adjusted EBITDA |
|
|
|
Reconciliation of GAAP Operating Loss to Non-GAAP Operating Income Forward Looking Guidance: | |
Fiscal Year 2025 | |
( |
|
GAAP operating loss |
|
GAAP operating margins | (10%) to (7%) |
Adjustments | |
Stock-based compensation expense |
|
Intangible assets amortization expense |
|
Reorganization and other |
|
Non-GAAP operating profit |
|
Non-GAAP operating margins | 4% to 5% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250508527742/en/
CCO & VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: